A Alharbi's scientific contributions

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)


Insight into Oncogenic Viral Pathways as Drivers of Viral Cancers: Implication for Effective Therapy
  • Literature Review
  • Full-text available

February 2023

·

118 Reads

·

6 Citations

Current Oncology

·

·

Ovais Shabir Shah

·

[...]

·

A Alharbi

As per a recent study conducted by the WHO, 15.4% of all cancers are caused by infectious agents of various categories, and more than 10% of them are attributed to viruses. The emergence of COVID-19 has once again diverted the scientific community’s attention toward viral diseases. Some researchers have postulated that SARS-CoV-2 will add its name to the growing list of oncogenic viruses in the long run. However, owing to the complexities in carcinogenesis of viral origin, researchers across the world are struggling to identify the common thread that runs across different oncogenic viruses. Classical pathways of viral oncogenesis have identified oncogenic mediators in oncogenic viruses, but these mediators have been reported to act on diverse cellular and multiple omics pathways. In addition to viral mediators of carcinogenesis, researchers have identified various host factors responsible for viral carcinogenesis. Henceforth owing to viral and host complexities in viral carcinogenesis, a singular mechanistic pathway remains yet to be established; hence there is an urgent need to integrate concepts from system biology, cancer microenvironment, evolutionary perspective, and thermodynamics to understand the role of viruses as drivers of cancer. In the present manuscript, we provide a holistic view of the pathogenic pathways involved in viral oncogenesis with special emphasis on alteration in the tumor microenvironment, genomic alteration, biological entropy, evolutionary selection, and host determinants involved in the pathogenesis of viral tumor genesis. These concepts can provide important insight into viral cancers, which can have an important implication for developing novel, effective, and personalized therapeutic options for treating viral cancers.

Download
Share

Citations (1)


... [123][124][125] Second, oncology patients are commonly transfused with blood products, which pose a possible route of HEV transmission. 126,127 Third, 15.4% of all cancers are caused by infectious agents of various categories, and more than 10% of them are attributed to viruses, including HBV and HCV. 126,127 It seems that the incidence of HEV in patients with neoplasms is similar in the general population. ...

Reference:

Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review
Insight into Oncogenic Viral Pathways as Drivers of Viral Cancers: Implication for Effective Therapy

Current Oncology